| Dr Tareq M Abu Salah, MD | |
|
1705 East Broadway, Suite 280, Columbia, MO 65201-7185 | |
| (573) 815-7118 | |
| (573) 815-7116 |
| Full Name | Dr Tareq M Abu Salah |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 27 Years |
| Location | 1705 East Broadway, Columbia, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417914474 | NPI | - | NPPES |
| 200008188 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 2009010821 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Boone Hospital Center | Columbia, MO | Hospital |
| Macon County Samaritan Memorial Hospital | Macon, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Boone Physician Services Llc | 6507090644 | 226 |
| Landmark Hospital Of Columbia, Llc | 2062568025 | 7 |
News Archive
State officials soon will ask Congress to grant them more regulatory authority over the marketing of private Medicare drug benefit and Medicare Advantage plans to respond to continuing complaints of aggressive marketing practices, the New York Times reports. In a draft report by the National Association of Insurance Commissioners, state officials propose creating a set of marketing standards for private Medicare plans that states, if they adopt them, would enforce.
Lupin Pharmaceuticals, Inc. has announced that it has received final approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Simvastatin Tablets 10mg, 20mg, 40mg and 80mg.
The AP reports on some of the measure's unexpected beneficiaries and The Christian Science Monitor details how it could be dismantled. Also, California Healthline follows the money that is lobbying to preserve the measure.
Merus Labs International Inc. is pleased to announce that Health Canada has approved its advanced wound care product Collexa. Collexa is exclusively licensed to Merus Labs by Innocoll for sales and distribution in Canada.
› Verified 1 days ago
| Entity Name | Landmark Hospital Of Columbia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972732378 PECOS PAC ID: 2062568025 Enrollment ID: O20100422000128 |
News Archive
State officials soon will ask Congress to grant them more regulatory authority over the marketing of private Medicare drug benefit and Medicare Advantage plans to respond to continuing complaints of aggressive marketing practices, the New York Times reports. In a draft report by the National Association of Insurance Commissioners, state officials propose creating a set of marketing standards for private Medicare plans that states, if they adopt them, would enforce.
Lupin Pharmaceuticals, Inc. has announced that it has received final approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Simvastatin Tablets 10mg, 20mg, 40mg and 80mg.
The AP reports on some of the measure's unexpected beneficiaries and The Christian Science Monitor details how it could be dismantled. Also, California Healthline follows the money that is lobbying to preserve the measure.
Merus Labs International Inc. is pleased to announce that Health Canada has approved its advanced wound care product Collexa. Collexa is exclusively licensed to Merus Labs by Innocoll for sales and distribution in Canada.
› Verified 1 days ago
| Entity Name | Boone Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760893259 PECOS PAC ID: 6507090644 Enrollment ID: O20131003000535 |
News Archive
State officials soon will ask Congress to grant them more regulatory authority over the marketing of private Medicare drug benefit and Medicare Advantage plans to respond to continuing complaints of aggressive marketing practices, the New York Times reports. In a draft report by the National Association of Insurance Commissioners, state officials propose creating a set of marketing standards for private Medicare plans that states, if they adopt them, would enforce.
Lupin Pharmaceuticals, Inc. has announced that it has received final approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Simvastatin Tablets 10mg, 20mg, 40mg and 80mg.
The AP reports on some of the measure's unexpected beneficiaries and The Christian Science Monitor details how it could be dismantled. Also, California Healthline follows the money that is lobbying to preserve the measure.
Merus Labs International Inc. is pleased to announce that Health Canada has approved its advanced wound care product Collexa. Collexa is exclusively licensed to Merus Labs by Innocoll for sales and distribution in Canada.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tareq M Abu Salah, MD 1705 East Broadway, Suite 280, Columbia, MO 65201-7185 Ph: (573) 815-7118 | Dr Tareq M Abu Salah, MD 1705 East Broadway, Suite 280, Columbia, MO 65201-7185 Ph: (573) 815-7118 |
News Archive
State officials soon will ask Congress to grant them more regulatory authority over the marketing of private Medicare drug benefit and Medicare Advantage plans to respond to continuing complaints of aggressive marketing practices, the New York Times reports. In a draft report by the National Association of Insurance Commissioners, state officials propose creating a set of marketing standards for private Medicare plans that states, if they adopt them, would enforce.
Lupin Pharmaceuticals, Inc. has announced that it has received final approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Simvastatin Tablets 10mg, 20mg, 40mg and 80mg.
The AP reports on some of the measure's unexpected beneficiaries and The Christian Science Monitor details how it could be dismantled. Also, California Healthline follows the money that is lobbying to preserve the measure.
Merus Labs International Inc. is pleased to announce that Health Canada has approved its advanced wound care product Collexa. Collexa is exclusively licensed to Merus Labs by Innocoll for sales and distribution in Canada.
› Verified 1 days ago
Dr. Rahul Jain, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Dr, Columbia, MO 65212 Phone: 573-884-2296 Fax: 573-884-7743 | |
Mr. Ghulam Ghous, M.D Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1 Hospital Dr, Columbia, MO 65212 Phone: 573-884-9066 Fax: 573-884-3037 | |
Gregory Gaskey, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1 Hospital Dr, Columbia, MO 65212 Phone: 573-884-9066 Fax: 573-884-3037 | |
Christos N Papageorgiou, M.D., PHD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: One Hospital Drive, Columbia, MO 65212 Phone: 573-882-2100 Fax: 573-884-7822 | |
Jack Bragg, DO Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 101 S Fairview Road, Columbia, MO 65201 Phone: 573-884-7600 Fax: 573-884-8200 | |
Michelle Middleton Woodson, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 800 Hospital Dr, Columbia, MO 65201 Phone: 573-814-6000 Fax: 573-814-6584 | |
Dr. Sameer Bellapravalu, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Drive Room 313, Psychiatry Dept Dc067.00, Columbia, MO 65212 Phone: 573-884-6136 Fax: 573-884-1070 |